Reuters -- Swiss drugmaker Novartis AG said on Tuesday it has launched a generic version of Astellas Pharma Inc's (4503.T) transplant drug Prograf, its biggest drug by revenue, helping send shares of the Japanese drugmaker 5 percent lower.
Reuters -- Swiss drugmaker Novartis AG said on Tuesday it has launched a generic version of Astellas Pharma Inc's (4503.T) transplant drug Prograf, its biggest drug by revenue, helping send shares of the Japanese drugmaker 5 percent lower.
